For over a year doctors told Byrd Vihlen that her bloating and abdominal pain were most likely caused by some sort of food allergy. When she started periodically needing to dash to a bathroom with diarrhea, the diagnosis changed to irritable bowel syndrome, a benign, but very unpleasant condition that affects muscle contractions of the gut.
Vihlen’s symptoms continued to worsen and the pain intensified. At her brother’s wedding she remembers spending much of the day in the bathroom dealing with bouts of diarrhea mixed with blood and mucous. Those new symptoms brought a new, more serious, diagnosis, inflammatory bowel disease, or IBD. It is an issue that she is now been dealing with for five years and has severely impacted her quality of life.
4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.
